prion diseases
prion pathologies
Neuroprotective human antibodies
humanized antibodies
cellular prion protein
flexible tail
anti-PrPC autoimmunity
proposed research program
rare anti-FT immunoreactive individuals
selected individuals
human memory B cells
proposed activities
high-yield method
high-throughput screening
persons devoid of pathologies
large populations
light chains
candidates
infectious neurodegenerative conditions
safety profiles superior
misfolding
investigational new drug
ERC-funded study
Health
team of Adriano Aguzzi
development of therapies
framework
clinical information
principal investigator
company
Completion
humans
antiprion therapeutics